# Gaudium IVF and Women Health (NSE: GAUDIUMIVF) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/GAUDIUMIVF · Pivot · prices to 22 Oct 2026

Gaudium IVF and Women Health (NSE: GAUDIUMIVF) closed at ₹95.11 on 22 Oct 2026, up 1.07% on the day. With a market capitalisation of ₹692 Cr, it ranks 1635th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 24.3× trailing earnings, against a return on equity of 16.1% in FY26. Its 52-week range is ₹69.18 (23 Mar 2026) to ₹163.18 (22 Jul 2026); the last close is 41.7% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹30 Cr (+12.7% year on year) and net profit ₹8 Cr (+29.6%), on a consolidated basis. Promoters held 71.29% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹95.11 |
| Market cap | ₹692 Cr |
| P/E (trailing) | 24.3 |
| ROE | 16.1% (FY26) |
| ROCE | 23.1% (FY26) |
| Debt to equity | 0.15 |
| 52-week high | ₹163.18 (22 Jul 2026) |
| 52-week low | ₹69.18 (23 Mar 2026) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹30 Cr | +12.7% | ₹8 Cr | +29.6% | ₹1.34 |
| Q3 FY26 | ₹25 Cr | +70.0% | ₹4 Cr | +6.8% | ₹0.59 |
| Q2 FY26 | ₹32 Cr | — | ₹9 Cr | — | ₹1.53 |
| Q1 FY26 | ₹18 Cr | — | ₹3 Cr | — | ₹0.51 |
| Q4 FY25 | ₹27 Cr | — | ₹6 Cr | — | ₹1.05 |
| Q3 FY25 | ₹14 Cr | — | ₹3 Cr | — | ₹0.55 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹71 Cr | ₹19 Cr |
| FY24 | ₹48 Cr | ₹10 Cr |
| FY23 | ₹44 Cr | ₹14 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 71.29%
- Foreign institutions: 3.02%
- Domestic institutions: 2.22%
- Non-institutions: 23.47%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Kilitch Drugs (India)](https://app.pivotnow.in/stock/KILITCH) | ₹215.00 | ₹752 Cr | 24.2 | — |
| [Vikram Thermo](https://app.pivotnow.in/stock/VIKRAMTH) | — | ₹728 Cr | — | — |
| [Zim Laboratories](https://app.pivotnow.in/stock/ZIMLAB) | ₹133.50 | ₹715 Cr | 112.2 | — |
| [Valiant Laboratories](https://app.pivotnow.in/stock/VALIANTLAB) | ₹131.05 | ₹712 Cr | — | — |
| [Amanta Healthcare](https://app.pivotnow.in/stock/AMANTA) | ₹182.55 | ₹709 Cr | 42.2 | — |
| [Wanbury](https://app.pivotnow.in/stock/WANBURY) | ₹185.66 | ₹649 Cr | 9.6 | — |

## Questions and answers

### What is the share price of Gaudium IVF and Women Health today?

Gaudium IVF and Women Health (NSE: GAUDIUMIVF) last closed at ₹95.11 on 22 Oct 2026. Its 52-week high is ₹163.18 and its 52-week low is ₹69.18.

### What is the market cap of Gaudium IVF and Women Health?

Gaudium IVF and Women Health's market capitalisation is ₹692 Cr (₹692 Cr) at the 22 Oct 2026 close, ranking 1635th among the NSE companies Pivot tracks.

### What is the P/E ratio of Gaudium IVF and Women Health?

Gaudium IVF and Women Health trades at a trailing P/E of 24.3. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 42.2.

### What is the ROE and ROCE of Gaudium IVF and Women Health?

Return on equity was 16.1% in FY26 and return on capital employed was 23.1% in FY26 (consolidated figures).

### Is Gaudium IVF and Women Health a debt-free company?

No. Gaudium IVF and Women Health's debt-to-equity ratio was 0.15 in FY26, with total debt of ₹0 Cr.

### What were Gaudium IVF and Women Health's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Gaudium IVF and Women Health reported revenue of ₹30 Cr, +12.7% year on year, and net profit of ₹8 Cr, +29.6% year on year.

### What is the shareholding pattern of Gaudium IVF and Women Health?

As of 30 Jun 2026: promoters 71.29%, foreign institutions 3.02%, domestic institutions 2.22%, non-institutions 23.47%.

### Who are Gaudium IVF and Women Health's competitors?

The listed Pharma & Healthcare companies closest to Gaudium IVF and Women Health by market cap are Kilitch Drugs (India), Vikram Thermo, Zim Laboratories, Valiant Laboratories, Amanta Healthcare and Wanbury.

### Is Gaudium IVF and Women Health a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Gaudium IVF and Women Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on GAUDIUMIVF against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.